How to Get Crestor (Rosuvastatin) in New Mexico

Rosuvastatin Prescribing Is Legal via Telehealth in New Mexico

New Mexico law authorizes licensed prescribers to evaluate patients and write prescriptions through synchronous audio-video telehealth encounters. This means a New Mexico resident can consult a physician, nurse practitioner, or physician assistant online and receive a rosuvastatin prescription without an in-person office visit. The New Mexico Medical Board updated its telemedicine rules under NMAC 16.10.2 to align with expanded access provisions that became permanent after the COVID-era waivers.

For rosuvastatin specifically, telehealth prescribing is straightforward. Statins are not controlled substances, so they carry none of the prescribing restrictions that apply to Schedule II through V drugs. A prescriber licensed in New Mexico (or holding a valid interstate compact license) can evaluate your cardiovascular risk profile, review recent lab work, and transmit the prescription electronically to any pharmacy you choose within the state.

Telehealth platforms that operate in New Mexico typically require you to upload a recent fasting lipid panel and liver function tests before the visit. If you do not have recent labs, most platforms will order them through a partner laboratory such as Quest Diagnostics or Labcorp, both of which have draw sites in Albuquerque, Las Cruces, Santa Fe, and Rio Rancho.

The 2008 JUPITER trial (N=17,802) demonstrated that rosuvastatin 20 mg reduced major cardiovascular events by 44% in patients with elevated high-sensitivity C-reactive protein (hsCRP) and LDL cholesterol below 130 mg/dL 1. That trial reshaped statin prescribing guidelines and remains a foundational reason clinicians prescribe rosuvastatin for primary prevention, even in patients whose LDL levels are not dramatically elevated.

Who Can Prescribe Crestor in New Mexico: MD, NP, and PA Scope

Three categories of clinicians can write a rosuvastatin prescription in New Mexico. Physicians (MDs and DOs) have unrestricted prescriptive authority. Nurse practitioners hold full practice authority under New Mexico's NP scope-of-practice law (NMSA 1978, Section 61-3-23.2), meaning they can independently diagnose, prescribe, and manage statin therapy without physician oversight. This makes New Mexico one of the more accessible states for NP-led telehealth statin prescribing.

Physician assistants in New Mexico prescribe under a collaborative practice agreement with a supervising physician. The PA can still prescribe rosuvastatin, but the agreement must be on file with the New Mexico Medical Board.

Pharmacists in New Mexico cannot independently prescribe rosuvastatin. They can, however, participate in collaborative practice agreements that allow therapeutic substitution (for example, switching between generic rosuvastatin manufacturers) or dose adjustments under a protocol signed by the supervising prescriber.

A practical note: if you are using a national telehealth platform, verify that the prescriber assigned to your visit holds an active New Mexico license. The Interstate Medical Licensure Compact includes New Mexico, so some out-of-state physicians may hold expedited NM licenses. You can verify any prescriber's license status through the New Mexico Medical Board online lookup tool.

Labs Required Before Starting Rosuvastatin

The 2018 ACC/AHA Cholesterol Clinical Practice Guideline recommends a fasting lipid panel before initiating statin therapy to establish baseline LDL-C, HDL-C, and triglyceride values 2. Most prescribers also require baseline hepatic transaminases (ALT and AST) because rosuvastatin, like all statins, carries a low but real risk of hepatotoxicity. The FDA-approved labeling for rosuvastatin recommends liver enzyme testing before initiating therapy and "as clinically indicated thereafter" 3.

A fasting glucose or HbA1c is also standard practice. The JUPITER trial data showed a statistically significant increase in physician-reported diabetes among rosuvastatin-treated participants (3.0% vs. 2.4% in the placebo group over a median 1.9 years of follow-up) 1. Knowing your baseline glucose status helps the prescriber weigh this risk.

In New Mexico, labs can be drawn at any of the following:

• Quest Diagnostics locations in Albuquerque, Santa Fe, Las Cruces, and Rio Rancho
• Labcorp service centers across the state
• Hospital-affiliated outpatient labs at UNM Health, Presbyterian Healthcare, and Christus St. Vincent
• Direct-to-consumer lab services ordered through telehealth platforms (results typically available in 24 to 48 hours)

If you already have lab results from within the past 12 months, most telehealth providers will accept those. Some will accept results up to 18 months old if your clinical picture has not changed.

Generic Rosuvastatin vs. Brand Crestor: Cost in New Mexico

Brand-name Crestor carries a retail price exceeding $350 per month in most U.S. pharmacies. Generic rosuvastatin, available since 2016 after patent expiration, costs dramatically less. At New Mexico retail pharmacies, cash-pay pricing for a 30-day supply of generic rosuvastatin typically falls between $8 and $25, depending on dose and pharmacy.

Pricing varies by pharmacy. Costco Pharmacy in Albuquerque and Walmart pharmacies across the state tend to offer the lowest generic rosuvastatin prices (often under $10 for 10 mg or 20 mg tablets). CVS, Walgreens, and Albertsons/Savon pharmacies are widely available in urban NM areas but may price slightly higher without a discount card or coupon.

GoodRx and RxSaver coupons can reduce the price further, sometimes to $4 to $8 at participating pharmacies. These coupons are accepted at most chain pharmacies in New Mexico and do not require insurance.

For patients with commercial insurance, rosuvastatin (generic) is typically placed on Tier 1 (preferred generic), resulting in copays of $0 to $15. Brand Crestor, if covered at all, usually sits on Tier 3 or higher, with copays of $50 to $150.

A 2022 analysis in the Journal of the American Heart Association found that statin adherence increased by 3.9 percentage points for each $10 decrease in out-of-pocket cost 4. Cost matters clinically: a cheaper generic that a patient actually takes outperforms an expensive brand that goes unfilled.

New Mexico Medicaid and Crestor Coverage

New Mexico Medicaid (Centennial Care 2.0, administered through managed care organizations such as Blue Cross Blue Shield of NM, Presbyterian Health Plan, and Western Sky Community Care) does not cover brand-name Crestor. The preferred drug list for hyperlipidemia agents generally includes generic statins: atorvastatin, simvastatin, pravastatin, and generic rosuvastatin.

Generic rosuvastatin may require prior authorization under certain Medicaid MCOs, particularly at higher doses (20 mg and 40 mg). The PA process typically requires the prescriber to document:

1. A current fasting lipid panel showing elevated LDL-C or elevated 10-year ASCVD risk score
2. The specific dose and indication (primary prevention, secondary prevention, or familial hypercholesterolemia)
3. Any previous statin trials and reasons for selecting rosuvastatin over formulary-preferred alternatives

PA decisions in New Mexico Medicaid must be made within 24 hours for standard requests and 4 hours for urgent requests, per federal Medicaid requirements under 42 CFR § 438.210.

If you are enrolled in a Medicare Part D plan in New Mexico, generic rosuvastatin is covered under most formularies. The 2025 Inflation Reduction Act provisions cap annual out-of-pocket Part D spending at $2,000, which benefits patients taking multiple branded medications but has minimal impact on those using low-cost generics.

503A Compounding Pharmacies in New Mexico

New Mexico permits licensed 503A compounding pharmacies to prepare rosuvastatin formulations under patient-specific prescriptions. This is relevant for patients who need non-standard dosing (for example, a 7.5 mg dose for patients sensitive to the standard 10 mg tablet) or who require an alternative dosage form such as a liquid suspension for patients with swallowing difficulties.

Under Section 503A of the Federal Food, Drug, and Cosmetic Act, these pharmacies compound medications based on individual prescriptions and cannot produce large batches for general distribution 5. The New Mexico Board of Pharmacy oversees state-level compounding regulations and inspects 503A facilities for compliance.

A few points to consider with compounded rosuvastatin:

• Compounded formulations are not FDA-approved and may have different bioavailability than commercial tablets
• Insurance plans rarely cover compounded medications
• Costs for compounded rosuvastatin are typically higher ($30 to $80 per month) than generic commercial tablets
• Compounding is most appropriate when a commercially available formulation genuinely does not meet the patient's clinical needs

For most New Mexico patients, a standard generic rosuvastatin tablet from a retail pharmacy is the simplest and least expensive option.

How to Transfer a Crestor Prescription to a New Mexico Pharmacy

If you have an existing rosuvastatin prescription from another state, transferring it to a New Mexico pharmacy is a routine process. You can:

• Call the receiving NM pharmacy and provide your current pharmacy's name and phone number. The pharmacist will initiate the transfer directly.
• Use your pharmacy chain's app (CVS, Walgreens, Walmart) to request an electronic transfer between locations.
• Ask your prescriber to send a new electronic prescription (e-Rx) to the NM pharmacy of your choice.

Prescription transfers for non-controlled medications like rosuvastatin are permitted across state lines. The receiving pharmacist contacts the originating pharmacy, verifies remaining refills, and processes the transfer. This typically takes 1 to 4 hours.

One limitation: New Mexico pharmacists cannot transfer a prescription that has zero remaining refills. In that case, you will need a new prescription from a licensed prescriber.

Timeline: How Long Until You Receive Rosuvastatin in New Mexico

The total time from initiating a telehealth visit to having rosuvastatin in hand depends on whether you already have qualifying lab work.

If you have recent labs (within 12 months):

• Telehealth consultation: same day or next day
• E-prescription transmitted: immediately after visit
• Pharmacy fill time: 1 to 4 hours (retail pickup) or 2 to 5 business days (mail order)

If you need new labs:

• Lab order placed: same day as initial intake
• Lab draw appointment: 1 to 3 days (depending on location availability)
• Results returned: 24 to 48 hours after draw
• Telehealth consultation: same day results are reviewed
• Prescription and fill: add 1 to 4 hours (retail) or 2 to 5 days (mail)

Total timeline with labs: approximately 4 to 8 days. Without labs: as fast as same-day.

Mail-order pharmacies that ship to New Mexico addresses (including Amazon Pharmacy, Cost Plus Drugs, and Express Scripts home delivery) can be a cost-effective option. Mark Cuban's Cost Plus Drugs prices generic rosuvastatin 10 mg at approximately $4.20 for a 30-day supply before shipping.

Prior Authorization Documentation in New Mexico

When a New Mexico insurer or Medicaid MCO requires prior authorization for rosuvastatin, the prescriber must submit specific documentation. The PA request form varies by payer, but common required elements include:

• Patient demographics and insurance ID
• Diagnosis code: E78.00 (pure hypercholesterolemia), E78.5 (hyperlipidemia, unspecified), or I25.10 (ASCVD) per ICD-10 coding standards
• Current fasting lipid panel with LDL-C, HDL-C, total cholesterol, and triglycerides
• 10-year ASCVD risk score calculated using the Pooled Cohort Equations recommended by the 2018 ACC/AHA guideline 2
• Step therapy documentation showing trials of formulary-preferred statins (typically atorvastatin or simvastatin) and clinical justification for rosuvastatin
• Clinical rationale for the specific dose requested

The 2018 ACC/AHA guideline identifies four statin benefit groups, and the PA is most straightforward when the prescriber clearly maps the patient to one of these groups 2:

1. Clinical ASCVD (secondary prevention)
2. LDL-C ≥ 190 mg/dL (severe hypercholesterolemia)
3. Diabetes, age 40 to 75, LDL-C 70 to 189 mg/dL
4. 10-year ASCVD risk ≥ 7.5%, age 40 to 75, LDL-C 70 to 189 mg/dL

Turnaround for commercial PA in New Mexico averages 2 to 5 business days. Urgent or expedited requests can sometimes be processed within 24 hours if the prescriber calls the payer directly.

Rosuvastatin Dosing and Monitoring After You Start

The FDA-approved dosing range for rosuvastatin is 5 mg to 40 mg once daily 3. Most patients start at 10 mg or 20 mg. The 40 mg dose is reserved for patients who do not achieve adequate LDL-C lowering at 20 mg and should be used only after careful evaluation of risk factors for myopathy.

A follow-up lipid panel is typically ordered 4 to 12 weeks after initiation or dose change, per the 2018 ACC/AHA guideline 2. The expected LDL-C reduction with rosuvastatin varies by dose:

• 5 mg: approximately 38% LDL-C reduction
• 10 mg: approximately 43% reduction
• 20 mg: approximately 48% reduction
• 40 mg: approximately 53% reduction

These values come from the STELLAR trial (N=2,431), which directly compared rosuvastatin against atorvastatin, simvastatin, and pravastatin across dose ranges 6. Rosuvastatin achieved the largest LDL-C reductions at every milligram-equivalent dose comparison.

Patients should report any unexplained muscle pain, tenderness, or weakness. Creatine kinase (CK) testing is not routinely recommended at baseline but should be obtained if myopathy symptoms develop. The incidence of rhabdomyolysis with rosuvastatin is approximately 1.6 per 100,000 patient-years based on post-marketing surveillance data 3.

The initial follow-up visit (in-person or telehealth) at 4 to 12 weeks should include a repeat fasting lipid panel and a clinical assessment of tolerability. If the patient is at LDL-C goal and tolerating the medication, subsequent monitoring every 3 to 12 months is standard.